| |
|
|
|
|
Micro Therapeutics, Inc.(MTIX)
|
|
|
|
|
|
|
|
|
| 123Jump Rating: |
|
Underwriters: |
UBS Securities
|
| |
|
|
Volpe, Welty
|
| Status: |
|
|
|
| |
| Address: |
1062 Calle Negocio #F
|
FiledDate: |
|
| |
|
|
|
| |
|
Filed Price Range ($): |
|
| |
|
|
|
| Telephone: |
714 361 0616 |
Filed Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Fax: |
|
Shares Offered (Millions): |
2,000,000 |
| |
|
|
|
| Websites: |
|
Shares Outstanding (Millions): |
6,556,462 |
| |
|
|
|
| Management: |
George Wallace, President/CEO
|
IPO Date: |
|
| |
Thomas Berryman, CFO
|
|
|
| |
William M. McLain, VP
|
Final Offer Price ($): |
$0.00 |
| |
|
|
|
| Industry: |
|
Final Offer Size (Millions of Shares): |
0.00 |
| |
|
|
|
| Employees: |
|
Final Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Competitors: |
Target Therapeutics
|
S-1 Forms: |
|
| |
Boston Scientific, Inc.
|
|
|
| |
Cordis, Inc.
|
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
- Avoid 
- Value Gap 
- Short-Term Growth
- Long-Term Growth 
- Long-Term Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Data |
| Year |
Revenues |
Costs |
Oper Income |
Taxes |
Net Income |
EPS |
| 1993
|
0.00 |
0.00 |
-116 |
1 |
-117 |
-.035 |
| 1994
|
26 |
26 |
-1316 |
1 |
-1300 |
-.383 |
| 1995
|
292 |
316 |
-3008 |
1 |
-2807 |
-.82 |
| 1996
|
1388 |
1633 |
-5784 |
1 |
-5614 |
-1.4 |
| 1993 June 11, 1993 - Dec. 31
| |
|
|
|
|
|
|
| |
|
| |
|
|
